Stocks · US
INCY
XNAS
Incyte Genomics Inc
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E14.35x
P/B3.65x
P/S3.98x
EPS$7.95
ROE25.41%
ROA20.48%
Dividend yield0.00%
EV/EBITDA9.88x
Debt/Equity0.01
Free cash flow$1.9B
Returns and 52-week range
1W-8.50%
1M-11.06%
3M-3.86%
6M+20.32%
1Y+29.80%
YTD+11.15%
52W high$132.60
52W low$82.81
From 52W high-14.98%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| 랩코프 | $25.0B | 24.97 | 2.91 | -4.64% |
| United Therapeutics Corp | $23.0B | 17.55 | 3.59 | +11.08% |
| 가단트 헬스 | $25.1B | — | — | +5.75% |
| Insmed, Inc. | $22.7B | — | 29.93 | -16.68% |
| Royalty Pharma plc Class A Ordinary Shares | $25.2B | 30.96 | 3.69 | -11.76% |
| Tenet Healthcare Corporation New | $20.9B | 9.32 | 4.49 | -2.48% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.